Lung cancer is cancer that starts in your lungs. It is the leading cause of cancer death among men and women. Finding lung cancer early before it spreads improves your chances of beating the disease.

Ateganosine combined with Libtayo shows improved progression-free survival in advanced non-small cell lung cancer, suggesting potential long-term use. Spevatamig, a bispecific antibody, is being ...